botiss is an innovative, clinically oriented medical and pharmaceutical company headquartered in Germany, with R&D and production sites in Germany, Austria, and Great Britain. Since the foundation of botiss biomaterials in 2009, botiss has become a leading developer, manufacturer and marketer of biomaterials for oral tissue regeneration. botiss stands for evidence-based know-how in bone and soft tissue regeneration. With innovative products, we are continuously developing our holistic 360° system together with international experts. The safety and reliability of our products is our top priority. The indication-oriented products are used worldwide in over 100 countries and are supported by both clinical studies and many years of clinical experience.